Adjunctive Thymosin Beta-4 Treatment Influences MΦ Effector Cell Function to Improve Disease Outcome in Pseudomonas aeruginosa-Induced Keratitis.
Quick Facts
What This Study Found
Tβ4 treatment significantly reduced reactive nitrogen species production and macrophage infiltration.
Key Numbers
How They Did This
The study used flow cytometry to analyze macrophage function and in vitro experiments with RAW 264.7 cells to confirm findings.
Why This Research Matters
Improving treatments for bacterial keratitis can enhance patient outcomes and reduce complications. Understanding macrophage behavior can inform future therapies.
What This Study Doesn't Tell Us
The study primarily used an experimental model, which may not fully replicate human responses.
Trust & Context
- Original Title:
- Adjunctive Thymosin Beta-4 Treatment Influences MΦ Effector Cell Function to Improve Disease Outcome in Pseudomonas aeruginosa-Induced Keratitis.
- Published In:
- International journal of molecular sciences, 22(20) (2021)
- Authors:
- Wang, Yuxin(2), Carion, Thomas W(2), Ebrahim, Abdul Shukkur(2), Sosne, Gabriel, Berger, Elizabeth A
- Database ID:
- RPEP-05866
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-05866APA
Wang, Yuxin; Carion, Thomas W; Ebrahim, Abdul Shukkur; Sosne, Gabriel; Berger, Elizabeth A. (2021). Adjunctive Thymosin Beta-4 Treatment Influences MΦ Effector Cell Function to Improve Disease Outcome in Pseudomonas aeruginosa-Induced Keratitis.. International journal of molecular sciences, 22(20). https://doi.org/10.3390/ijms222011016
MLA
Wang, Yuxin, et al. "Adjunctive Thymosin Beta-4 Treatment Influences MΦ Effector Cell Function to Improve Disease Outcome in Pseudomonas aeruginosa-Induced Keratitis.." International journal of molecular sciences, 2021. https://doi.org/10.3390/ijms222011016
RethinkPeptides
RethinkPeptides Research Database. "Adjunctive Thymosin Beta-4 Treatment Influences MΦ Effector ..." RPEP-05866. Retrieved from https://rethinkpeptides.com/research/wang-2021-adjunctive-thymosin-beta4-treatment-2
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.